Mark Raffeld - Concepedia

Author

Mark Raffeld

Also Known As

Juha Kononen, Kenneth D. Aldape, Liqiang Xi, M Raffeld, M. RAFFELD, M. Raffeld, Mark A. Raffeld, Mark Raffeld, Mark Raffeld, MD, Mark. Raffeld

795

Publications

47.7K

Citations

113

H-Index

196

Concepts

All Affiliations

National Cancer Institute National Institutes of Health Center for Cancer Research National Institute of Allergy and Infectious Diseases National Institutes of Health Clinical Center

About

Mark Raffeld is an author at National Cancer Institute specializing in medicine, pathology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	68	163	14.5K
2	Health Sciences	15	15	1.2K
3	Allergy	9	9	452
4	Engineering	4	4	586
5	Natural Sciences	1	1	61

Mark Raffeld

354

Publications

43.3K

Citations

110

H-Index

Page 1

	Year	Citations
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes Mark E. Dudley, John R. Wunderlich, Paul F. Robbins, Science	2002	2.8K
Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor James N. Kochenderfer, Mark E. Dudley, Sadik H. Kassim, Journal of Clinical Oncology	2014	1.6K
Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1 Paul F. Robbins, Richard A. Morgan, Steven A. Feldman, Journal of Clinical Oncology	2011	1.6K
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19 James N. Kochenderfer, Wyndham H. Wilson, John E. Janik, Blood	2010	1.3K
The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia Yair Herishanu, Patricia Pérez‐Galán, Delong Liu, Blood	2010	811
A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response Paul F. Robbins, Sadik H. Kassim, Thai L.N. Tran, Clinical Cancer Research	2014	780
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma Aarif Y. Khakoo, Shibani Pati, Stasia A. Anderson, The Journal of Experimental Medicine	2006	744
B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma Robert O. Carpenter, Moses O. Evbuomwan, Stefania Pittaluga, Clinical Cancer Research	2013	652
Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome Amy P. Hsu, Elizabeth P. Sampaio, Javed Khan, Blood	2011	629
Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma Barbara Ensoli, Rita Gendelman, Phillip D. Markham, Nature Human RetrovirusHiv-1 Tat ProteinImmunologyPathologyHiv	1994	569

Page 1